The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Apomorphine HCL (Brand name: Apokyn®)
- Manufactured by
Ipsen Limited
FDA-approved indication: For the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose-wearing-off" and unpredictable :on/off" episodes) associated with advanced Parkinson's disease
National Library of Medicine Drug Information PortalMedline Plus Health Information